Jonathan Meiss Siner MD

Assistant Professor of Medicine (Pulmonary); Medical Director - Medical Intensive Care Unit, Yale-New Haven Hospital

Clinical Interests

Intensive Care Medicine (Critical Care); Acute Respiratory Distress Syndrome (ARDS); Sepsis; Interstitial Lung Diseases (ILD); Idiopathic Pulmonary Fibrosis (IPF)


Board Certifications

2005
Critical Care Medicine (Internal Medicine), Board Certified
2001
Internal Medicine, Board Certified

Patient Care Locations

jonathan_sinerfaculty-clinicsfalsetruetrue6truefalsefalse

Clinical Trials

ConditionsStudy Title
Idiopathic Pulmonary Fibrosis(FG-3019-067) A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of FG-3019 in Patients with Idiopathic Pulmonary Fibrosis
Alpha 1 Antitrypsin Deficiency and AATD(GRADS)(A) - Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis
Idiopathic Pulmonary Fibrosis(RAINIER) A Phase 2, Randomized, Double Blind, Placebo Controlled, Multi-Center Study to Assess the Efficacy and safety of GS-6624 in Subjects with Idiopathic Pulmonary Fibrosis (GS-US-322-027)
Sarcoidosis(GRADS)(B) - Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidsosis
Idiopathic Pulmonary Fibrosis(GB28547) A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients with Idiopathic Pulmonary Fibrosis

More Clinical Trials...

Edit Profile